Literature DB >> 17123271

Second primary cancers after prostatic irradiation: ensuring an appropriate analysis.

Wayne Kendal, Libni Eapen, Garth Nicholas.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17123271     DOI： 10.1002/cncr.22377

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.

Authors:  Laura A Rechner; Rebecca M Howell; Rui Zhang; Carol Etzel; Andrew K Lee; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2012-10-10       Impact factor: 3.609

2.  Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.

Authors:  Stefan Lönn; Ethel S Gilbert; Elaine Ron; Susan A Smith; Marilyn Stovall; Rochelle E Curtis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

3.  Secondary malignancies following radiotherapy for prostate cancer.

Authors:  Petros Sountoulides; Nikolaos Koletsas; Dimitris Kikidakis; Konstantinos Paschalidis; Nikolaos Sofikitis
Journal:  Ther Adv Urol       Date:  2010-06

Review 4.  Evolved Cellular Mechanisms to Respond to Genotoxic Insults: Implications for Radiation-Induced Hematologic Malignancies.

Authors:  Courtney J Fleenor; Kelly Higa; Michael M Weil; James DeGregori
Journal:  Radiat Res       Date:  2015-09-28       Impact factor: 2.841

Review 5.  Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.

Authors:  Louise Murray; Ann Henry; Peter Hoskin; Frank-Andre Siebert; Jack Venselaar
Journal:  Radiother Oncol       Date:  2014-01-30       Impact factor: 6.280

6.  Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung.

Authors:  Neeta Somaiah; Mary Jo Fidler; Elizabeth Garrett-Mayer; Amy Wahlquist; Keisuke Shirai; Lela Buckingham; Thomas Hensing; Philip Bonomi; George R Simon
Journal:  Oncoscience       Date:  2014-08-07

7.  Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.

Authors:  Nina-Sophie Hegemann; Anne Schlesinger-Raab; Ute Ganswindt; Claudia Hörl; Stephanie E Combs; Dieter Hölzel; Jürgen E Gschwend; Christian Stief; Claus Belka; Jutta Engel
Journal:  Radiat Oncol       Date:  2017-01-03       Impact factor: 3.481

8.  Evaluation of surface and shallow depth dose reductions using a Superflab bolus during conventional and advanced external beam radiotherapy.

Authors:  Jihyung Yoon; Yibo Xie; Rui Zhang
Journal:  J Appl Clin Med Phys       Date:  2018-02-10       Impact factor: 2.102

9.  Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients.

Authors:  Lu Zhang; Mei-Chin Hsieh; Claire Allison; Michael Devane; Chindo Hicks; Qingzhao Yu; Lu Shi; Jiande Wu; Xiao-Cheng Wu
Journal:  Cancer Epidemiol       Date:  2021-06-17       Impact factor: 2.890

Review 10.  Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum.

Authors:  G F Nash; K J Turner; T Hickish; J Smith; M Chand; B J Moran
Journal:  Ann R Coll Surg Engl       Date:  2012-10       Impact factor: 1.891
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.